Can Aripiprazole and Lamotrigine be used to treat a patient with PTSD and comorbid Bipolar Mood Disorder?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 16, 2026 • View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Can Aripiprazole and Lamotrigine Be Used Together for PTSD and Comorbid Bipolar Disorder?

Yes, aripiprazole and lamotrigine can be used together for a patient with PTSD and comorbid bipolar disorder, as this combination addresses both mood stabilization and potential psychotic or manic symptoms, with lamotrigine providing particular benefit for the depressive pole of bipolar disorder and aripiprazole offering antimanic and antipsychotic effects. 1

Evidence-Based Rationale for This Combination

Aripiprazole in Bipolar Disorder

  • Aripiprazole is recommended as a first-line treatment for acute mania and maintenance therapy in bipolar disorder, with FDA approval for these indications and a favorable metabolic profile compared to other atypical antipsychotics like olanzapine. 1, 2

  • The American Academy of Child and Adolescent Psychiatry recommends aripiprazole as standard therapy along with lithium and valproate for acute mania, with typical dosing of 5-15 mg/day. 1, 3

  • Aripiprazole combined with mood stabilizers (lithium or valproate) is superior to monotherapy for both acute symptom control and relapse prevention in bipolar I disorder. 1, 4

  • Aripiprazole has proven efficacy for acute mania and prevention of manic relapse, though evidence for treating acute bipolar depression and preventing depressive relapse is less robust. 5

Lamotrigine in Bipolar Disorder

  • Lamotrigine is FDA-approved for maintenance therapy in bipolar disorder and is particularly effective for preventing depressive episodes, making it an excellent choice for the depressive pole of the illness. 1, 6, 2

  • Most guidelines recommend lamotrigine as a first-line maintenance option, though acute monotherapy studies for bipolar depression have failed to show superiority over placebo. 6

  • Lamotrigine significantly delays time to intervention for any mood episode compared to placebo in maintenance treatment of bipolar I disorder. 1

Safety of the Combination

  • Lamotrigine has few significant drug interactions with aripiprazole, making it a safe addition to this regimen. 1

  • The combination of aripiprazole with mood stabilizers presents a lower risk of metabolic side effects compared with other combination therapies, though it increases the risk of extrapyramidal side effects with long-term treatment. 4

Critical Implementation Algorithm

Starting Lamotrigine

  • Lamotrigine MUST be titrated slowly to minimize the risk of Stevens-Johnson syndrome and serious rash, which can be fatal if rapid loading is attempted. 1

  • Standard titration schedule:

    • Weeks 1-2: 25 mg daily
    • Weeks 3-4: 50 mg daily
    • Week 5: 100 mg daily
    • Week 6+: 200 mg daily (target maintenance dose) 1

  • If lamotrigine is discontinued for more than 5 days, restart with the full titration schedule rather than resuming the previous dose to minimize rash risk. 1

Aripiprazole Dosing

  • Start aripiprazole at 5-10 mg daily, with a therapeutic range of 5-15 mg/day for bipolar disorder. 1, 3

  • Aripiprazole can be initiated immediately for rapid symptom control if the patient is experiencing acute manic or psychotic symptoms. 1

Monitoring Requirements

  • Monitor weekly for any signs of rash during the first 8 weeks of lamotrigine titration, and assess mood symptoms, suicidal ideation, and medication adherence at each visit. 1

  • For aripiprazole, baseline metabolic monitoring should include BMI, waist circumference, blood pressure, fasting glucose, and fasting lipid panel, with follow-up BMI monthly for 3 months then quarterly, and blood pressure, glucose, lipids at 3 months then yearly. 1

  • Schedule follow-up visits every 1-2 weeks initially during lamotrigine titration, then monthly once stable. 1

Addressing PTSD Symptoms

Important Caveat

  • Neither aripiprazole nor lamotrigine is FDA-approved or considered first-line treatment for PTSD specifically. The provided evidence focuses on bipolar disorder treatment, not PTSD.

  • For PTSD, evidence-based first-line treatments typically include SSRIs (sertraline, paroxetine) and trauma-focused psychotherapy (prolonged exposure, cognitive processing therapy), though these were not addressed in the provided evidence.

Potential Benefits for Comorbid Symptoms

  • The aripiprazole-lamotrigine combination may help with mood instability, irritability, and emotional dysregulation that can occur in both PTSD and bipolar disorder. 1, 4

  • Aripiprazole may provide benefit for hyperarousal symptoms, agitation, and intrusive thoughts that can occur in PTSD, though this is an off-label use. 3

  • The combination may be particularly useful when PTSD symptoms include significant mood instability, psychotic features, or manic symptoms that complicate the clinical picture. 4

Maintenance and Long-Term Considerations

  • Maintenance therapy should continue for at least 12-24 months after mood stabilization, with some patients requiring lifelong treatment, particularly those with multiple severe episodes or rapid cycling. 1, 2

  • Withdrawal of maintenance therapy dramatically increases relapse risk, with over 90% of noncompliant patients relapsing versus 37.5% of compliant patients. 1

  • Long-term treatment with lithium, lamotrigine, valproate, olanzapine, quetiapine, and aripiprazole are recommended first-line maintenance options for bipolar disorder. 6, 2

Common Pitfalls to Avoid

  • Never rapid-load lamotrigine - this dramatically increases risk of Stevens-Johnson syndrome, which can be fatal. 1

  • Do not use antidepressants as monotherapy in bipolar disorder due to risk of mood destabilization, mania induction, and rapid cycling. 1, 6, 2

  • Inadequate duration of maintenance therapy leads to high relapse rates - continue treatment for at least 12-24 months minimum. 1

  • Failure to monitor for metabolic side effects of aripiprazole, particularly weight gain, glucose abnormalities, and lipid changes. 1

  • Premature discontinuation of effective medications - more than 50% of patients with bipolar disorder are not adherent to treatment, contributing to poor outcomes. 2

References

1
Guideline

First-Line Treatment of Bipolar Disorder

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Related Questions

What is the best alternative treatment for a patient with bipolar depression who cannot take lithium, between Abilify (aripiprazole) and Seroquel (quetiapine)?
What is a suitable second medication to treat depression in an 81-year-old female patient with chronic kidney disease (CKD), one kidney, bipolar disorder, and a recent suicidal attempt, currently being treated with 10mg of Abilify (aripiprazole)?
What is a suitable PRN (as-needed) medication for anxiety in a patient with bipolar 1 disorder, currently taking Abilify (aripiprazole) and lithium, who experiences sedation with hydroxyzine?
What adjustments should be made to the treatment regimen for a 22-year-old patient with bipolar disorder currently taking lamotrigine (Lamictal) 25mg and quetiapine (Seroquel) 50mg?
Is the current medication regimen of Abilify (Aripiprazole) 7mg, Lexapro (Escitalopram) 10mg, Trazodone 50mg at bedtime, and Hydroxyzine 50mg twice a day as needed, effective for managing bipolar disorder?
What is the best course of action for an 8-year-old child, weighing 16-17 kg, with a diagnosis of benign occipital lobe epilepsy, who is experiencing break-through seizures despite being on levetiracetam (~29 mg/kg/day) and oxcarbazepine (150 mg twice daily, ~18 mg/kg/day)?
What is the recommended dose of Albendazole (anti-parasitic medication) for a patient?
Is Klomifen (Clomiphene) safe for ovulation induction in a patient with Multiple Sclerosis (MS)?
Was it a mistake not to start a selective serotonin reuptake inhibitor (SSRI) immediately for a patient with post-traumatic stress disorder (PTSD) and comorbid bipolar mood disorder?
Is it safe to start Memantine in an elderly patient with vascular and Alzheimer's dementia, bipolar disorder, and a pacemaker, who is currently taking Verapamil, Clopidogrel, Divalproex, and Risperidone?
What is the management for a patient with acute exacerbation of Chronic Obstructive Pulmonary Disease (COPD) and Coronary Artery Disease (CAD) presenting with tachycardia?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question